Production (Stage)
Context Therapeutics Inc.
CNTX
$0.6101
-$0.0193-3.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.35M | 94.43M | 84.80M | 101.54M | 10.09M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.18M | 3.47M | 1.27M | 1.16M | 949.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | -- | -- | -- | -- |
| Total Current Assets | 92.73M | 97.90M | 86.07M | 102.70M | 11.04M |
|
|
|||||
| Total Current Assets | 92.73M | 97.90M | 86.07M | 102.70M | 11.04M |
| Net Property, Plant & Equipment | 234.70K | 230.80K | 259.00K | 10.40K | 13.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 92.97M | 98.13M | 86.33M | 102.71M | 11.05M |
|
|
|||||
| Total Accounts Payable | 1.00M | 1.45M | 1.03M | 611.50K | 2.05M |
| Total Accrued Expenses | 710.40K | 2.33M | 1.11M | 981.80K | 549.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 111.10K | 107.30K | 104.20K | -- | -- |
| Total Finance Division Other Current Liabilities | 77.30K | 49.80K | 89.80K | 11.00K | 13.70K |
| Total Other Current Liabilities | 77.30K | 49.80K | 89.80K | 11.00K | 13.70K |
| Total Current Liabilities | 1.90M | 2.75M | 2.33M | 1.60M | 2.61M |
|
|
|||||
| Total Current Liabilities | 1.90M | 2.75M | 2.33M | 1.60M | 2.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 82.60K | 112.10K | 140.20K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.98M | 2.86M | 2.47M | 1.60M | 2.61M |
|
|
|||||
| Common Stock & APIC | 190.34M | 190.05M | 175.29M | 175.08M | 80.17M |
| Retained Earnings | -99.36M | -94.78M | -91.44M | -73.98M | -71.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 90.98M | 95.27M | 83.86M | 101.10M | 8.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.98M | 95.27M | 83.86M | 101.10M | 8.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.98M | 95.27M | 83.86M | 101.10M | 8.44M |
|
|
|||||